UroGen Pharma Ltd. (FRA:UR8)
Germany · Delayed Price · Currency is EUR 24.40
-0.60 (-2.40%)
Last updated: Dec 1, 2025, 8:10 AM CET
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of €1.15 billion as of December 1, 2025. Its market cap has increased by 133.30% in one year.
Market Cap
1.15B
Enterprise Value
1.15B
Revenue
82.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€24.40
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from 152.95M to 1.15B, an increase of 649.23%. That is a compound annual growth rate of 26.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.16B | 167.91% |
| Dec 31, 2024 | 434.10M | 3.64% |
| Dec 29, 2023 | 418.87M | 118.57% |
| Dec 30, 2022 | 191.64M | 2.22% |
| Dec 31, 2021 | 187.48M | -42.39% |
| Dec 31, 2020 | 325.46M | -47.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |